Kenvue, the Johnson & Johnson consumer health spin-off, has seen its stock price collapse amid legal uncertainties and management turmoil. While the company’s strong brand portfolio and cash flow suggest value, significant risks remain for investors considering this dip.
The next generation of STEM students faces an AI-transformed landscape. From data security to neurodegenerative disease research, these students are adapting their career strategies for an uncertain future.
Tata Consultancy Services denies losing a Marks & Spencer service desk contract following a cyber-attack. The dispute reveals deeper challenges in cybersecurity accountability across global IT outsourcing relationships.
Citi Ventures has built one of Wall Street’s most formidable corporate venture arms over 15 years, making 200+ investments and 30 exits. The operation balances financial returns with strategic technology development for Citibank’s evolving needs.
Oracle faces mounting pressure from cloud competitors and specialized data platforms. Our analysis examines whether Oracle can maintain its enterprise dominance amid shifting market dynamics.
Major market moves reflect shifting geopolitical and M&A landscapes. A potential U.S.-China trade truce is reshaping commodity and semiconductor sectors, while Novartis’s $12 billion acquisition signals biotech consolidation. Here’s what these movements mean for investors.
Researchers have demonstrated optical skyrmions performing integer arithmetic with inherent noise resistance. This topological approach could overcome fundamental limitations in photonic computing scalability. The technology represents a paradigm shift from conventional photonic architectures.
Steven Pinker’s latest research explores how common knowledge—the awareness of mutual understanding—shapes everything from social norms to financial bubbles. His work explains why public signals enable coordination that private knowledge cannot achieve.
Bridgewater’s Ray Dalio reveals America’s dangerous economic split: 1% driving growth while 60% struggle with basic literacy. This dependency threatens long-term stability as wealth gaps widen.
Stockholm-based Cellcolabs has raised €10.3 million to revolutionize stem cell accessibility through scalable manufacturing. The funding signals growing investor confidence in making regenerative medicine affordable and widely available. This could transform how research and therapies are developed
